These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16176192)

  • 1. Five-year risk of developing clinical diabetes after first myocardial infarction; the FINAMI study.
    Pajunen P; Koukkunen H; Ketonen M; Jerkkola T; Immonen-Räihä P; Kärjä-Koskenkari P; Mähönen M; Niemelä M; Kuulasmaa K; Palomäki P; Mustonen J; Lehtonen A; Arstila M; Vuorenmaa T; Lehto S; Miettinen H; Juolevi A; Torppa J; Tuomilehto J; Kesäniemi YA; Pyörälä K; Salomaa V
    Diabet Med; 2005 Oct; 22(10):1334-7. PubMed ID: 16176192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial.
    Vaccaro O; Eberly LE; Neaton JD; Yang L; Riccardi G; Stamler J;
    Arch Intern Med; 2004 Jul; 164(13):1438-43. PubMed ID: 15249353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favourable trends in the incidence and outcome of myocardial infarction in nondiabetic, but not in diabetic, subjects: findings from the MONICA myocardial infarction registry in northern Sweden in 1989-2000.
    Rautio A; Lundberg V; Messner T; Nasic S; Stegmayr B; Eliasson M
    J Intern Med; 2005 Oct; 258(4):369-77. PubMed ID: 16164577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease.
    Hu G; Jousilahti P; Qiao Q; Peltonen M; Katoh S; Tuomilehto J
    J Am Coll Cardiol; 2005 May; 45(9):1413-8. PubMed ID: 15862411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study.
    Pajunen P; Koukkunen H; Ketonen M; Jerkkola T; Immonen-Räihä P; Kärjä-Koskenkari P; Kuulasmaa K; Palomäki P; Mustonen J; Lehtonen A; Arstila M; Vuorenmaa T; Lehto S; Miettinen H; Torppa J; Tuomilehto J; Kesäniemi YA; Pyörälä K; Salomaa V
    Diabetologia; 2005 Dec; 48(12):2519-24. PubMed ID: 16247597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary events in persons aged 75 years or older in Finland from 1995 to 2002: the FINAMI study.
    Koukkunen H; Salomaa V; Lehto S; Ketonen M; Immonen-Räihä P; Lehtonen A; Havulinna A; Kesäniemi YA; Pyörälä K;
    Am J Geriatr Cardiol; 2008; 17(2):78-86. PubMed ID: 18326953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
    Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study.
    Horsdal HT; Johnsen SP; Søndergaard F; Jacobsen J; Thomsen RW; Schmitz O; Sørensen HT; Rungby J
    Diabetes Metab Res Rev; 2009 Sep; 25(6):515-22. PubMed ID: 19459168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognosis after coronary artery bypass surgery.
    Ketonen M; Pajunen P; Koukkunen H; Immonen-Räihä P; Mustonen J; Mähönen M; Niemelä M; Kuulasmaa K; Palomäki P; Arstila M; Vuorenmaa T; Lehtonen A; Lehto S; Miettinen H; Torppa J; Tuomilehto J; Airaksinen J; Pyörälä K; Salomaa V;
    Int J Cardiol; 2008 Feb; 124(1):72-9. PubMed ID: 17383028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP).
    Leander K; Wiman B; Hallqvist J; Andersson T; Ahlbom A; de Faire U
    Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):532-7. PubMed ID: 17667644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
    Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
    Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
    Lewis EF; Velazquez EJ; Solomon SD; Hellkamp AS; McMurray JJ; Mathias J; Rouleau JL; Maggioni AP; Swedberg K; Kober L; White H; Dalby AJ; Francis GS; Zannad F; Califf RM; Pfeffer MA
    Eur Heart J; 2008 Mar; 29(6):748-56. PubMed ID: 18308687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antecedent risk factors and their control in young patients with a first myocardial infarction.
    Chan MY; Woo KS; Wong HB; Chia BL; Sutandar A; Tan HC
    Singapore Med J; 2006 Jan; 47(1):27-30. PubMed ID: 16397717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is diabetes an independent risk factor for mortality after myocardial infarction? The ARIC (Atherosclerosis Risk in Communities) Surveillance Study.
    Weitzman S; Wang C; Rosamond WD; Chambless LE; Cooper LS; Shahar E; Goff DC;
    Acta Diabetol; 2004 Jun; 41(2):77-83. PubMed ID: 15224209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.
    Brar SS; Kim J; Brar SK; Zadegan R; Ree M; Liu IL; Mansukhani P; Aharonian V; Hyett R; Shen AY
    J Am Coll Cardiol; 2008 Jun; 51(23):2220-7. PubMed ID: 18534267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Return to work after first myocardial infarction in 1991-1996 in Finland.
    Hämäläinen H; Mäki J; Virta L; Keskimäki I; Mähönen M; Moltchanov V; Salomaa V
    Eur J Public Health; 2004 Dec; 14(4):350-3. PubMed ID: 15542868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of sports activities in leisure time and incident myocardial infarction in middle-aged men and women from the general population: the MONICA/KORA Augsburg cohort study.
    Meisinger C; Löwel H; Heier M; Kandler U; Döring A
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):788-92. PubMed ID: 18043300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.